The Art Of Planning And Managing A Research Laboratory

[Ed. note: Max Perutz shared the 1962 Nobel Prize in chemistiy with John Kendrew for developing the X-ray diffraction techniques that revealed the structures of macromolecules and, thereby launched the science of molecular biology. But more recently, he has been lauded for his spectacular success as a manager of scientists. In particular, the accolades single out his tenure as head of the Medical Research Council’s molecular biology laboratory in Cambridge, from 1947 to 1979. What makes

Written byMax Perutz
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

[Ed. note: Max Perutz shared the 1962 Nobel Prize in chemistiy with John Kendrew for developing the X-ray diffraction techniques that revealed the structures of macromolecules and, thereby launched the science of molecular biology. But more recently, he has been lauded for his spectacular success as a manager of scientists. In particular, the accolades single out his tenure as head of the Medical Research Council’s molecular biology laboratory in Cambridge, from 1947 to 1979. What makes a good manager? The Scientist asked Perutz for his opinion.]

In 1959, when the Unit for Molecular Biology was still part of the Cavendish Laboratory, our budding fame brought a Soviet delegation to discover how I had planned the unit. Had I selected staff as Noah gathered animals for his Ark—two mathematicians, two physicists, two biochemists, and two biologists—and waited for their discoveries to hatch? Our visitors did not believe me when I said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies